• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩展的汉森溶解度方法:美洛昔康在单一溶剂中的情况

Extended Hansen's solubility approach: meloxicam in individual solvents.

作者信息

Babu P R Sathesh, Subrahmanyam C V S, Thimmasetty J, Manavalan R, Valliappan K

机构信息

Bapuji Pharmacy College, Davangere, Karnataka, India.

出版信息

Pak J Pharm Sci. 2007 Oct;20(4):311-6.

PMID:17604255
Abstract

The solubility behaviour of meloxicam in individual solvents ranging from non-polar to highly polar was studied. For understanding the solute-solvent interactions, partial solubility parameters concept was utilized. The extended Hansen's method was used for analyzing the solubility data and for obtaining partial solubility parameters of meloxicam. The analysis was not successful though correlations were 81%. The Flory-Huggins size correction term 'B' was found to improve the prediction of solubility. The correlations were high (92%) and total solubility parameter was 11.6 H. The four-parameter approach involving proton-donor and proton-acceptor parameters was also used in fitting the solubility data. The correlations were appreciable (87%) and total solubility parameter was 11.2 H. The term 'B' combined with four-parameter approach was also used in order to improve the data, and was found to be improved the correlations (R2=0.94). This new approach may thus be used in fitting the experimental solubility data and to predict solubility behaviour of meloxicam in untested solvents. The total solubility parameter of meloxicam was assigned at 11.2 H.

摘要

研究了美洛昔康在从非极性到高极性的各种单一溶剂中的溶解行为。为了理解溶质 - 溶剂相互作用,采用了部分溶解度参数概念。扩展的汉森方法用于分析溶解度数据并获得美洛昔康的部分溶解度参数。尽管相关性为81%,但分析并不成功。发现弗洛里 - 哈金斯尺寸校正项“B”可改善溶解度预测。相关性很高(92%),总溶解度参数为11.6 H。涉及质子供体和质子受体参数的四参数方法也用于拟合溶解度数据。相关性相当可观(87%),总溶解度参数为11.2 H。“B”项与四参数方法相结合也用于改进数据,发现相关性得到了提高(R2 = 0.94)。因此,这种新方法可用于拟合实验溶解度数据并预测美洛昔康在未测试溶剂中的溶解行为。美洛昔康的总溶解度参数设定为11.2 H。

相似文献

1
Extended Hansen's solubility approach: meloxicam in individual solvents.扩展的汉森溶解度方法:美洛昔康在单一溶剂中的情况
Pak J Pharm Sci. 2007 Oct;20(4):311-6.
2
Solubility behaviour of haloperidol in individual solvents determination of partial solubility parameters.氟哌啶醇在单一溶剂中的溶解行为及部分溶解度参数的测定
Eur J Pharm Biopharm. 1999 May;47(3):289-94. doi: 10.1016/s0939-6411(98)00079-4.
3
Predicting the solubility of sulfamethoxypyridazine in individual solvents. I: Calculating partial solubility parameters.预测磺胺甲氧嗪在单一溶剂中的溶解度。I:计算偏溶解度参数。
J Pharm Sci. 1989 Jul;78(7):567-73. doi: 10.1002/jps.2600780712.
4
Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.非甾体抗炎药(NSAIDs)昔康类药物的光物理研究:吡罗昔康、美洛昔康和替诺昔康。
Spectrochim Acta A Mol Biomol Spectrosc. 2003 Apr;59(6):1213-22. doi: 10.1016/s1386-1425(02)00300-1.
5
The effect of mixed-solvent and terpenes on percutaneous absorption of meloxicam gel.混合溶剂和萜类化合物对美洛昔康凝胶经皮吸收的影响。
Drug Dev Ind Pharm. 2007 Sep;33(9):984-9. doi: 10.1080/03639040601150294.
6
Determination of Solubility Parameters of Ibuprofen and Ibuprofen Lysinate.布洛芬和赖氨匹林溶解度参数的测定
Molecules. 2015 Dec 3;20(12):21549-68. doi: 10.3390/molecules201219777.
7
Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.药物共晶开发中的共晶形成剂选择:以具有增强溶解性和药代动力学的美洛昔康-阿司匹林共晶为例。
J Pharm Sci. 2011 Jun;100(6):2172-81. doi: 10.1002/jps.22434. Epub 2010 Dec 22.
8
Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.研究改善难溶性美洛昔康溶解性能的制备参数。
Int J Pharm. 2009 Nov 3;381(2):153-9. doi: 10.1016/j.ijpharm.2009.07.009. Epub 2009 Jul 17.
9
Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.作为多供体配体系统的抗炎性昔康类药物:美洛昔康和吡罗昔康与钌和锇的pH和溶剂依赖性配位模式
Chemistry. 2017 Apr 6;23(20):4893-4902. doi: 10.1002/chem.201700263. Epub 2017 Mar 21.
10
Analysis of polymorphic contamination in meloxicam raw materials and its effects on the physicochemical quality of drug product.分析美洛昔康原料药中的多态性污染及其对药物产品理化性质的影响。
Eur J Pharm Sci. 2017 Nov 15;109:347-358. doi: 10.1016/j.ejps.2017.08.029. Epub 2017 Aug 24.

引用本文的文献

1
Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model.用于美洛昔康眼部给药的壳聚糖纳米颗粒:在兔眼模型中的研发、体外表征及体内评价
Pharmaceutics. 2022 Apr 20;14(5):893. doi: 10.3390/pharmaceutics14050893.
2
Determination of Solubility Parameters of Ibuprofen and Ibuprofen Lysinate.布洛芬和赖氨匹林溶解度参数的测定
Molecules. 2015 Dec 3;20(12):21549-68. doi: 10.3390/molecules201219777.
3
Solubility prediction of satranidazole in propylene glycol-water mixtures using extended hildebrand solubility approach.
使用扩展的希尔德布兰德溶解度方法预测塞曲硝唑在丙二醇 - 水混合物中的溶解度。
Indian J Pharm Sci. 2011 Nov;73(6):670-4. doi: 10.4103/0250-474X.100243.
4
Extended hildebrand solubility approach: satranidazole in mixtures of dioxane and water.扩展的希尔德布兰德溶解度方法:沙硝唑在二氧六环与水的混合物中的情况
Indian J Pharm Sci. 2011 May;73(3):315-9. doi: 10.4103/0250-474X.93518.